The incidence of brainstem toxicity following high-dose conformal proton therapy for adult skull-base malignanciesFootnote

* Abstract presented at the annual Particle Therapy Co-Operative Group (PTCOG) meeting in Miami, FL on June 30th, 2022.

References

• Mercado CE, Holtzman AL, Rotondo R, et al. Proton therapy for skull base tumors: a review of clinical outcomes for chordomas and chondrosarcomas. Head Neck. 2019;41(2):536–541.
   PubMed Web of Science ®Google Scholar
• Lawrence YR, Li XA, el Naqa I, et al. Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys. 2010;76(3):S20–S7.
   PubMed Web of Science ®Google Scholar
• Palm RF, Oliver DE, Yang GQ, et al. The role of dose escalation and proton therapy in perioperative or definitive treatment of chondrosarcoma and chordoma: an analysis of the national cancer data base. Cancer. 2019;125(4):642–651.
   PubMed Web of Science ®Google Scholar
• Holtzman AL, Bates JE, Morris CG, et al. Impact of type of treatment center and access to care on mortality and survival for skull base chordoma and chondrosarcoma. J Neurol Surg Part B Skull Base. 2021;83(3):328–338.
   PubMed Web of Science ®Google Scholar
• Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991; 21(1):109–122.
   PubMed Web of Science ®Google Scholar
• Debus J, Hug EB, Liebsch NJ, et al. Brainstem tolerance to conformal radiotherapy of skull base tumors. Int J Radiat Oncol Biol Phys. 1997;39(5):967–975.
   PubMed Web of Science ®Google Scholar
• Debus J, Hug EB, Liebsch NJ, et al. Dose-volume tolerance of the brainstem after high-dose radiotherapy. Front Radiat Ther Oncol. 1999;33:305–314.
   PubMedGoogle Scholar
• Rogers CL, Won M, Vogelbaum MA, et al. High-risk meningioma: Initial outcomes from NRG oncology/RTOG 0539. Int J Radiat Oncol Biol Phys. 2020;106(4):790–799.
   PubMed Web of Science ®Google Scholar
• Rogers L, Zhang P, Vogelbaum MA, et al. Intermediate-risk meningioma: initial outcomes from NRG oncology RTOG 0539. J Neurosurg. 2018;129(1):35–47.
   PubMed Web of Science ®Google Scholar
• Weber DC, Malyapa R, Albertini F, et al. Long term outcomes of patients with skull-base low-grade chondrosarcoma and chordoma patients treated with pencil beam scanning proton therapy. Radiother Oncol. 2016;120(1):169–174.
   PubMed Web of Science ®Google Scholar
• Mayo C, Yorke E, Merchant TE. Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys. 2010; 76(3):S36–S41.
   PubMed Web of Science ®Google Scholar
• Holtzman AL, Rotondo RL, Rutenberg MS, et al. Clinical outcomes following dose-escalated proton therapy for skull-base chordoma. Int J Part Ther. 2021;8(1):179–188.
   PubMedGoogle Scholar
• Holtzman AL, Rotondo RL, Rutenberg MS, et al. Proton therapy for skull-base chondrosarcoma, a single-institution outcomes study. J Neurooncol. 2019; 142(3):557–563.
   PubMed Web of Science ®Google Scholar
• Deraniyagala RL, Yeung D, Mendenhall WM, et al. Proton therapy for skull base chordomas: an outcome study from the university of Florida proton therapy institute. J Neurol Surg B Skull Base. 2014;75(1):53–57.
   PubMed Web of Science ®Google Scholar
• De Leo AN, Holtzman AL, Ho MW, et al. Vision loss following high-dose proton-based radiotherapy for skull-base chordoma and chondrosarcoma. Radiother Oncol. 2021;158:125–130.
   PubMed Web of Science ®Google Scholar
• Indelicato DJ, Flampouri S, Rotondo RL, et al. Incidence and dosimetric parameters of pediatric brainstem toxicity following proton therapy. Acta Oncol. 2014;53(10):1298–1304.
   PubMed Web of Science ®Google Scholar
• Haas-Kogan D, Indelicato D, Paganetti H, et al. National cancer institute workshop on proton therapy for children: considerations regarding brainstem injury. Int J Radiat Oncol Biol Phys. 2018;101(1):152–168.
   PubMed Web of Science ®Google Scholar
• Fung V, Calugaru V, Bolle S, et al. Proton beam therapy for skull base chordomas in 106 patients: a dose adaptive radiation protocol. Radiother Oncol. 2018;128(2):198–202.
   PubMed Web of Science ®Google Scholar
• Feuvret L, Bracci S, Calugaru V, et al. Efficacy and safety of adjuvant proton therapy combined with surgery for chondrosarcoma of the skull base: a retrospective, population-based study. Int J Radiat Oncol Biol Phys. 2016;95(1):312–321.
   PubMed Web of Science ®Google Scholar
• Sahgal A, Chan MW, Atenafu EG, et al. Image-guided, intensity-modulated radiation therapy (IG-IMRT) for skull base chordoma and chondrosarcoma: preliminary outcomes. Neuro Oncol. 2015;17(6):889–894.
   PubMed Web of Science ®Google Scholar
• Sorensen BS, Bassler N, Nielsen S, et al. Relative biological effectiveness (RBE) and distal edge effects of proton radiation on early damage in vivo. Acta Oncol. 2017;56(11):1387–1391.
   PubMed Web of Science ®Google Scholar
• Paganetti H, Blakely E, Carabe-Fernandez A, et al. Report of the AAPM TG-256 on the relative biological effectiveness of proton beams in radiation therapy. Med Phys. 2019;46(3):e53–e78.
   PubMed Web of Science ®Google Scholar
• Zhang YY, Huo WL, Goldberg SI, et al. Brain-Specific relative biological effectiveness of protons based on long-term outcome of patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2021;110(4):984–992.
   PubMed Web of Science ®Google Scholar